A phase I/II clinical trial of intravenous (IV) calcitriol with fixed dose of cisplatin and docetaxel in advanced non-small cell lung cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Calcitriol (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2017 Biomarkers information updated
- 22 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.